Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29700092 | 1.00 | FFAR4 (0.62) | FFAR4FFAR1KDM4EALDH1A1LMNA | |
| SCHEMBL1694946 | 0.91 | KDM4E (0.60) | FFAR4FFAR1KDM4EALDH1A1LMNA | |
| SCHEMBL21533581 | 0.85 | FFAR4 (0.58) | FFAR4FFAR1KDM4EALDH1A1LMNA | |
| SCHEMBL7827991 | 0.85 | MCL1 (0.69) | FFAR4FFAR1KDM4EALDH1A1LMNA | |
| SCHEMBL2654810 | 0.83 | S1PR1 (0.53) | FFAR4FFAR1CYP2C9SCN5A | |
| SCHEMBL31448501 | 0.81 | PPARA (0.65) | FFAR4FFAR1LMNA | |
| SCHEMBL12621163 | 0.81 | KDM4E (0.61) | KDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL13244184 | 0.81 | FFAR4 (0.53) | FFAR4FFAR1CYP2C9SCN5A | |
| SCHEMBL11724413 | 0.81 | KDM4E (0.56) | KDM4EALDH1A1LMNASMN1; SMN2POLB | |
| SCHEMBL120716 | 0.80 | KMT2A (0.58) | FFAR4FFAR1ALDH1A1LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210112809-A1 | METHODS FOR REDUCING THE VOLATILITY AND TOXICITY OF CLOMAZONE | FMC CORPORATION | 2021-04-22 | — | — | US | claimed |
| WO-2018169862-A1 | METHODS FOR REDUCING THE VOLATILITY AND TOXICITY OF CLOMAZONE | FMC CORPORATION (US) | 2018-09-20 | — | — | WO | claimed |
| US-20160143279-A1 | Methods for Improving the Efficacy of Anionic Herbicides under Hard Water Conditions and Suitable Compositions | BASF SE (DE) | 2016-05-26 | — | — | US | claimed |
| WO-2014206835-A1 | METHODS FOR IMPROVING THE EFFICACY OF ANIONIC HERBICIDES UNDER HARD WATER CONDITIONS AND SUITABLE COMPOSITIONS | BASF SE (DE) | 2014-12-31 | — | — | WO | claimed |
| US-8765639-B2 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | AKZO NOBEL N.V. (NL) | 2014-07-01 | — | — | US | claimed |
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2013-05-09 | — | — | US | claimed |
| EP-2405759-A2 | HERBICIDAL FORMULATIONS COMPRISING GLYPHOSATE AND ALKOXYLATED GLYCERIDES | Monsanto Technology LLC (US) | 2012-01-18 | — | — | EP | claimed |
| EP-2161992-B1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | AKZO NOBEL NV (NL) | 2010-11-17 | — | — | EP | claimed |
| WO-2010105047-A2 | HERBICIDAL FORMULATIONS COMPRISING GLYPHOSATE AND ALKOXYLATED GLYCERIDES | MONSANTO TECHNOLOGY LLC (US) | 2010-09-16 | — | — | WO | claimed |
| US-20100204047-A1 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | AKZO NOBEL N.V. (NL) | 2010-08-12 | — | — | US | claimed |
| EP-2161992-A1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | Akzo Nobel N.V. (NL) | 2010-03-17 | — | — | EP | claimed |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | MONSANTO TECHNOLOGY LLC (US) | 2010-03-04 | — | — | US | claimed |
| WO-2007109791-A9 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL NV (NL) | 2009-01-15 | — | — | WO | claimed |
| WO-2009004044-A1 | ALKOXYLATED ASYMMETRIC ALKYLAMINE SURFACTANTS AS ADJUVANTS | AKZO NOBEL N.V. (NL) | 2009-01-08 | — | — | WO | claimed |
| EP-2003965-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | Akzo Nobel N.V. (NL) | 2008-12-24 | — | — | EP | claimed |
| WO-2007109791-A2 | ALKOXYLATED ALKYLAMINES OR ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | AKZO NOBEL N.V. (NL) | 2007-09-27 | — | — | WO | claimed |
| US-12453351-B2 | Herbicide compatibility improvement | MONSANTO TECHNOLOGY LLC (US) | 2025-10-28 | — | — | US | disclosed |
| US-20240215573-A1 | LIQUID AGROCHEMICAL COMPOSITION | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-07-04 | — | — | US | disclosed |
| US-4086240-A | 1-Thiazolyl-5-phenoxy and phenylthioalkanoyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1978-04-25 | — | — | US | disclosed |
| US-4053480-A | 1-THIADIAZOLYL-5-PHENOXY- AND PHENYLTHIOALKANOYLOXY IMIDAZOLIDINONES | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160143279-A1 | Methods for Improving the Efficacy of Anionic Herbicides under Hard Water Conditions and Suitable Compositions | IDUA, GRIN2D, GMDS | FFAR4 2251/4885FFAR1 1965/4885KDM4E 1428/4885 |
| US-20130116120-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | FFAR4 178/4885FFAR1 164/4885KDM4E 1003/4885 |
| US-20100056376-A1 | ALKOXYLATED ALKYLAMINES/ALKYL ETHER AMINES WITH PEAKED DISTRIBUTION | ALK, ALKBH3, NAT1 | FFAR4 178/4885FFAR1 164/4885KDM4E 1003/4885 |
| US-12453351-B2 | Herbicide compatibility improvement | KCNH1, GRIK3, GRIK4 | FFAR4 689/4885FFAR1 1122/4885KDM4E 1473/4885 |
| US-20100204047-A1 | Alkoxylated asymmetric alkylamine surfactants as adjuvants | ALK, CHRM2, CHRM1 | FFAR4 193/4885FFAR1 81/4885KDM4E 1534/4885 |
| US-20240215573-A1 | LIQUID AGROCHEMICAL COMPOSITION | DAGLA, DAGLB, MGLL | FFAR4 135/4885FFAR1 443/4885KDM4E 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.